(Q45709087)

English

Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies

scientific article published in December 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1 reference

based on heuristic

inferred from title

author name string

Huttner NA

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Girod A

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Perabo L

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Edbauer D

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Kleinschmidt JA

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Büning H

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Hallek M

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

2139-2147

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Adeno-associated virus 2 co-receptors?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Integrin alphaVbeta5 is not involved in adeno-associated virus type 2 (AAV2) infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Real-time single-molecule imaging of the infection pathway of an adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Electron cryo-microscopy and image reconstruction of adeno-associated virus type 2 empty capsids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Insertional mutagenesis of AAV2 capsid and the production of recombinant virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Immune responses to adenovirus and adeno-associated virus in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Recombinant adeno-associated virus for muscle directed gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Structure, sequence, and function correlations among parvoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

The structure of human parvovirus B19 at 8 A resolution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

The three-dimensional structure of canine parvovirus and its functional implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

21 January 2018

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

7 January 2021

based on heuristic

inferred from DOI database lookup

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

7 January 2021

based on heuristic

inferred from DOI database lookup

Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302123

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3302123

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Dimensions Publication ID

0 references

release_ik6kdvx265h2vdthk2irfkfmja

1 reference

https://api.fatcat.wiki/v0/release/ik6kdvx265h2vdthk2irfkfmja

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45709087&oldid=2207270564"